Microinvasive carcinoma of the uterine cervix

  • Špela Srkolj
  • Renata Košir Pogačnik
  • Stelio Rakar

Abstract

Abstract: Cervical cancer is the second most common type of cancer among women in the world, and is one of the leading causes of death among cancer deaths in developing countries. The incidence rate of cervical cancer for Slovenia in 2009 was 12.5 per 100,000 females; by frequency it takes the eighth place among female cancers. Microinvasive carcinoma of the cervix is carcinoma with maximum depth of stromal invasion of 5 mm and maximum horizontal spread of 7 mm. The objective of this review is to present the definition of microinvasive carcinoma of the uterine cervix, to define the diagnostic protocol and treatment of patients with microinvasive carcinoma of the uterine cervix.

Downloads

Download data is not yet available.
Published
2011-06-01
How to Cite
1.
Srkolj Špela, Košir Pogačnik R, Rakar S. Microinvasive carcinoma of the uterine cervix. TEST ZdravVestn [Internet]. 1Jun.2011 [cited 5Aug.2024];80(6). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/156
Issue
Vol 80 No 6 (2011): June
Section
Review


The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence. 

Most read articles by the same author(s)